Charles Addams hit me like a meteor when I was around nine years old, and I have a particular affection for the great George ...

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a ...

The company has also announced the launch of its latest AI product suite, with further releases planned in the coming months. Social Media Marketing Initiative To improve sales performance and ...

ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T ™) products for cancer and autoimmune disease, today announced that the U.S. Food and Drug ...

an investigational allogeneic CAR T product. The Phase 1 RESOLUTION basket trial will evaluate the safety and preliminary efficacy of ALLO-329 in patients with systemic lupus erythematosus ...

Henlius investigational daratumumab biosimilar candidate ... Henlius is eligible to receive royalties on annual net sales of the product. The agreement combines Dr. Reddy’s global commercial ...

Riad Sattouf’s saga of his parents’ failed bicultural marriage, with its harsh depiction of life in rural Syria, has become a literary sensation. By Richard Fausset Richard Fausset reported ...

The CTX scheme involves the sponsors submitting an application to conduct one or more clinical trials with a particular investigational product to the TGA for evaluation and comment. However ...

Magdalena aiming to submit Investigational New Drug (IND ... are defined by the U.S. Food and Drug Administration (FDA) as "products from plant materials, algae, macroscopic fungi, and ...

CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug ...

TORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life ...